Prospective Study of <i>FGFR3</i> Mutations As a Prognostic Factor in Nonmuscle Invasive Urothelial Bladder Carcinomas

Abstract

The findings of this large study strongly support the notion that FGFR3 mutations characterize a subgroup of bladder cancers with good prognosis; patients with mutant TaG1 tumors have a higher risk of recurrence; and the F386L variant is selectively associated with low-grade tumors.